Diffuse Large B Cell Lymphoma Clinical Trials in Ningbo, Zhejiang
3 recruitingNingbo, Zhejiang, China
Showing 1–3 of 3 trials
Recruiting
Phase 2
Clinical Study of HiR+X Therapy for Newly Diagnosed Elderly Patients with DLBCL Intolerant to Chemotherapy
Diffuse Large B Cell LymphomaDLBCL
First Affiliated Hospital of Ningbo University50 enrolled1 locationNCT06758037
Recruiting
Phase 2
CHiR Therapy for Elderly DLBCL Intolerant to Chemo
Diffuse Large B Cell Lymphoma
First Affiliated Hospital of Ningbo University30 enrolled1 locationNCT06764017
Recruiting
Phase 1
CD19 CAR-T Expressing IL-7 and CCL19 Combined With Anti-PD1 in RR-DLBCL
Diffuse Large B Cell Lymphoma
Ningbo No. 1 Hospital24 enrolled2 locationsNCT05659628